[Pressor effect of angiotensin II and norepinephrine in patients with hypertension treated with alpha methyldopa].
D000804:Angiotensin II / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002752:Chlorthalidone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism; D006977:Hypertension, Renal / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D008722:Methods; D008750:Methyldopa / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D012867:Skin / Q000098:blood supply / Q000378:metabolism; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000804:Angiotensin II; D008750:Methyldopa; D002752:Chlorthalidone; D009638:Norepinephrine
Action pressive de l'angiotensine II et de la noradrénaline chez l'hypertendu traité par l'alpha méthyl dopa.